Xiao Hui Ji
Directeur/Bestuurslid bij LEGEND BIOTECH CORPORATION
Vermogen: 368 632 $ op 31-05-2024
Profiel
Xiao Hui Ji is the founder of Elpiscience Biopharma Ltd.
(founded in 2017) and holds the title of Chairman & Chief Executive Officer.
Dr. Ji is also the founder of PharmaLegacy Laboratories (Shanghai) Co., Ltd.
.
Dr. Ji's current job is as an Independent Director at Legend Biotech Corp.
since 2020.
Dr. Ji's former jobs include being a Director at The BayHelix Group from 2008 to 2013, Vice President-Business Development at Roche Holding AG from 2013 to 2016, and a Partner at LAV Management Co., Ltd.
from 2017 to 2020.
Dr. Ji's education history includes an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
0.01% | 31-12-2023 | 18 427 ( 0.01% ) | 368 632 $ | 31-05-2024 |
Actieve functies van Xiao Hui Ji
| Bedrijven | Functie | Begin |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Directeur/Bestuurslid | 01-05-2020 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Algemeen Directeur | 01-06-2017 |
Eerdere bekende functies van Xiao Hui Ji
| Bedrijven | Functie | Einde |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 01-05-2020 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01-12-2016 |
| The BayHelix Group | Directeur/Bestuurslid | 01-01-2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Algemeen Directeur | 01-01-2012 |
Opleiding van Xiao Hui Ji
| China Medical University | Doctorate Degree |
| The University of Sheffield | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
| The BayHelix Group | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
